Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 5 , Pages 225-231 , September 2007

Antiplatelet Effect of Losartan and Telmisartan in Patients With Ischemic Stroke

References 

  1. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet. 1995;346:1647–1653
  2. Omae T, Ueda K. Hypertension and cerebrovascular disease–the Japanese experience. J Hypertens. 1988;6:343–349
  3. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular diseases in the Asia-pacific region. J Hypertens. 2003;21:707–716
  4. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1: Prolonged differences in blood pressure; prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–774
  5. UK-TIA Study Group. The United Kingdom transient ischemic attack (UK-TIA) aspirin trial results. J Neurol Neurosurg Psychiatry. 1991;54:1044–1054
  6. Gorelick PB. Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke. 2002;33:862–875
  7. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomized trial against atenolol. Lancet. 2002;359:995–1003
  8. Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res. 2001;104:197–205
  9. Marquardt L, Ruf A, Mansmann U, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33:2570–2574
  10. Guerra-Cuesta JI, Monton M, Rodriguez-Feo JA, et al. Effect of losartan on human platelet activation. J Hypertens. 1999;17:447–452
  11. Nunez A, Gomez J, Zalba LR, et al. Losartan inhibits in vitro platelet activation: Comparison with candesartan and valsartan. J Renin Angiotensin Aldosterone Syst. 2000;1:175–179
  12. Monton M, Jimenez A, Nunez A, et al. Comparative effect of angiotensin II AT-1-type receptor antagonist in vitro on human platelet activation. J Cardiovasc Pharmacol. 2000;35:906–913
  13. Levy PJ, Yunis C, Owen J, et al. Inhibition of platelet aggregability by losartan in essential hypertension. Am J Cardiol. 2000;86:1188–1192
  14. Schwemmer M, Sommer O, Bassenge E. Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling. Cardiovasc Drugs Ther. 2001;15:301–307
  15. Kramer C, Sunkomat J, Witte J, et al. Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: Role of the active metabolite EXP3179. Circ Res. 2002;90:770–776
  16. Kalinowski L, Matys T, Chabielska E, et al. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension. 2002;40:521–527
  17. Nomura S, Shouzu A, Omoto S, et al. Losartan and simvastatin inhibit platelet activation in hypertensive patients. J Thromb Thrombolysis. 2004;18:177–185
  18. Ozaki Y, Satoh K, Yatomi Y, et al. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem. 1994;218:284–294
  19. Whisnant JP, Basford JR, Bernstein EF, et al. Special report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular disease III. Stroke. 1990;21:637–676
  20. Cherian P, Hankey GJ, Eikelboom JW, et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke. 2003;34:2132–2137
  21. Buczko W, Matys T, Pawlak R, et al. Studies on the antithrombotic action of AT1 receptor antagonists. Med Sci Monit. 2001;7:600–605
  22. Owens P, Kelly L, Nallen R, et al. Comparison of antihypertensive and metabolite effects of losartan and losartan in combination with hydrochlorothiazide–a randomized controlled trial. J Hypertens. 2000;18:339–345
  23. Akdemir R, Ozhan H, Yazici M, et al. In vivo effect of losartan on platelet aggregation in patients with hypertension. Heart Vessels. 2004;19:167–171

PII: S1052-3057(07)00105-X

doi: 10.1016/j.jstrokecerebrovasdis.2007.07.003

Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 5 , Pages 225-231 , September 2007

Article Tools

* Image Usage & Resolution